Norleual TFA
Norleual TFA is a potent small molecule inhibitor of the HGF/c-Met pathway with an IC50 of 3 pM. This angiotensin IV analog also acts as an AT4 receptor antagonist and exhibits antiangiogenic properties, making it a useful research tool for studying cancer, angiogenesis, and related pathologies in experimental models.
Product Specifications
Field of Research
Immunology & Inflammation, Metabolism Research, Signal Transduction
Molecular Weight
888.97
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog